PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of PharmaCyte Biotech Inc..
PharmaCyte Biotech Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of PharmaCyte Biotech Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of PharmaCyte Biotech Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of PharmaCyte Biotech Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of PharmaCyte Biotech Inc. and all latest updates of the company are provided.
The 2025 version of PharmaCyte Biotech Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 PharmaCyte Biotech Inc.- Key Facts
2.2 PharmaCyte Biotech Inc.- Geographic Locations
2.3 PharmaCyte Biotech Inc.- Subsidiaries and Affiliates
2.4 PharmaCyte Biotech Inc.- Business Divisions
2.5 PharmaCyte Biotech Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. PharmaCyte Biotech Inc. Strategic Analysis Review
3.1 PharmaCyte Biotech Inc.- Key Strategies
3.2 PharmaCyte Biotech Inc.- Company Outlook Statement
3.3 PharmaCyte Biotech Inc.- SWOT Analysis
3.3.1 PharmaCyte Biotech Inc.- Key Strengths
3.3.2 PharmaCyte Biotech Inc.- Key Weaknesses
3.3.3 PharmaCyte Biotech Inc.- Potential Opportunities
3.3.4 PharmaCyte Biotech Inc.- Potential Threats
3.4 PharmaCyte Biotech Inc.- Key Competitors
4. Business Description of the Company
4.1 PharmaCyte Biotech Inc.- Business Overview
4.2 PharmaCyte Biotech Inc.- Operations by Segment
5 Products and Services Details
5.1 PharmaCyte Biotech Inc.- Key Products
5.2 PharmaCyte Biotech Inc.- Key Service Areas
5.3 PharmaCyte Biotech Inc.- Key Brands
6 Company Developments
6.1 PharmaCyte Biotech Inc.- Company History
6.2 PharmaCyte Biotech Inc.- Latest Developments
7 Financial Analysis
7.1 PharmaCyte Biotech Inc.- Income Statements
7.2 PharmaCyte Biotech Inc.- Balance Sheet
7.3 PharmaCyte Biotech Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 PharmaCyte Biotech Inc.- Direct Competitors
8.2 PharmaCyte Biotech Inc.- Competitor Financial Ratios comparison
8.3 PharmaCyte Biotech Inc.- Competitor Stock Charts Comparison
8.4 PharmaCyte Biotech Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!